<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f2 { font-family:ff8,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f3 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f4 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f5 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f6 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f7 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f8 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page8.png">
<div class="txt" style="position:absolute; left:56px; top:113px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨 가치 </span><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">4,520</span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:191px; top:111px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">우리는 솔리암페톨의 파이프라인 가치를 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4,520</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원으로 추정한다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨의</span></div>
<div class="txt" style="position:absolute; left:191px; top:127px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 매출 전망과 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜의 매출</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로열티 수익</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로 인식되는 판매 로열티</span></div>
<div class="txt" style="position:absolute; left:191px; top:143px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">매출의 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">13%)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Evaluate Pharma</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 추정치를 적용했다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨의 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">peak</span></div>
<div class="txt" style="position:absolute; left:191px; top:159px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">매출은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2028</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">6.1</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(6,800</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 달할 것으로 전망된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">아시아 매출은</span></div>
<div class="txt" style="position:absolute; left:191px; top:175px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜이 현재까지는 판매 계획이 없어 가치산정에 포함하지 않았다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">아시</span></div>
<div class="txt" style="position:absolute; left:191px; top:191px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">아 판매에 대한 계획이 가시화될 경우 추가적인 파이프라인 가치의 상승이 기대</span></div>
<div class="txt" style="position:absolute; left:191px; top:207px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">그 외 할인율 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">7.5%, </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">영구성장률 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">-2%, </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">달러환율 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1,150</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">원</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">법인세율 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">20%</span></div>
<div class="txt" style="position:absolute; left:191px; top:223px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">를 적용했다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:56px; top:254px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">5&gt; </span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨 파이프라인 가치</span></div>
<div class="txt" style="position:absolute; left:56px; top:283px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 매출</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">아시아제외</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">백만달러</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:62px; top:294px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">로열티수입</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(13%)</span></div>
<div class="txt" style="position:absolute; left:62px; top:305px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">로열티수입</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:62px; top:317px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">로열티수입 현가환산</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:56px; top:328px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">세후 로열티 수입</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:56px; top:340px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">현금흐름 합산</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:56px; top:351px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">현금흐름 영구가치</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:56px; top:362px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NPV(</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:56px; top:377px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:221px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2019F</span></div>
<div class="txt" style="position:absolute; left:233px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">39</span></div>
<div class="txt" style="position:absolute; left:236px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span></div>
<div class="txt" style="position:absolute; left:236px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span></div>
<div class="txt" style="position:absolute; left:236px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span></div>
<div class="txt" style="position:absolute; left:236px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">4</span></div>
<div class="txt" style="position:absolute; left:229px; top:340px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">248</span></div>
<div class="txt" style="position:absolute; left:229px; top:351px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">204</span></div>
<div class="txt" style="position:absolute; left:229px; top:362px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">452</span></div>
<div class="txt" style="position:absolute; left:258px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2020F</span></div>
<div class="txt" style="position:absolute; left:266px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">127</span></div>
<div class="txt" style="position:absolute; left:270px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">17</span></div>
<div class="txt" style="position:absolute; left:270px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">19</span></div>
<div class="txt" style="position:absolute; left:270px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">17</span></div>
<div class="txt" style="position:absolute; left:270px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">13</span></div>
<div class="txt" style="position:absolute; left:295px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2021F</span></div>
<div class="txt" style="position:absolute; left:303px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">222</span></div>
<div class="txt" style="position:absolute; left:307px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">29</span></div>
<div class="txt" style="position:absolute; left:307px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">33</span></div>
<div class="txt" style="position:absolute; left:307px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">27</span></div>
<div class="txt" style="position:absolute; left:307px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">22</span></div>
<div class="txt" style="position:absolute; left:332px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2022F</span></div>
<div class="txt" style="position:absolute; left:340px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">311</span></div>
<div class="txt" style="position:absolute; left:344px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">40</span></div>
<div class="txt" style="position:absolute; left:344px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">46</span></div>
<div class="txt" style="position:absolute; left:344px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">36</span></div>
<div class="txt" style="position:absolute; left:344px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">29</span></div>
<div class="txt" style="position:absolute; left:369px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2023F</span></div>
<div class="txt" style="position:absolute; left:377px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">382</span></div>
<div class="txt" style="position:absolute; left:381px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">50</span></div>
<div class="txt" style="position:absolute; left:381px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">57</span></div>
<div class="txt" style="position:absolute; left:381px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">41</span></div>
<div class="txt" style="position:absolute; left:381px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">33</span></div>
<div class="txt" style="position:absolute; left:406px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2024F</span></div>
<div class="txt" style="position:absolute; left:414px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">450</span></div>
<div class="txt" style="position:absolute; left:418px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">58</span></div>
<div class="txt" style="position:absolute; left:418px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">67</span></div>
<div class="txt" style="position:absolute; left:418px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">45</span></div>
<div class="txt" style="position:absolute; left:418px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">36</span></div>
<div class="txt" style="position:absolute; left:443px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2025F</span></div>
<div class="txt" style="position:absolute; left:451px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500</span></div>
<div class="txt" style="position:absolute; left:455px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">65</span></div>
<div class="txt" style="position:absolute; left:455px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">75</span></div>
<div class="txt" style="position:absolute; left:455px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">46</span></div>
<div class="txt" style="position:absolute; left:455px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">37</span></div>
<div class="txt" style="position:absolute; left:480px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2026F</span></div>
<div class="txt" style="position:absolute; left:488px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">543</span></div>
<div class="txt" style="position:absolute; left:492px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">71</span></div>
<div class="txt" style="position:absolute; left:492px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">81</span></div>
<div class="txt" style="position:absolute; left:492px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">47</span></div>
<div class="txt" style="position:absolute; left:492px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">37</span></div>
<div class="txt" style="position:absolute; left:517px; top:271px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2027F</span></div>
<div class="txt" style="position:absolute; left:525px; top:283px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">579</span></div>
<div class="txt" style="position:absolute; left:529px; top:294px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">75</span></div>
<div class="txt" style="position:absolute; left:529px; top:305px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">87</span></div>
<div class="txt" style="position:absolute; left:529px; top:317px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">46</span></div>
<div class="txt" style="position:absolute; left:529px; top:328px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">37</span></div>
<div class="txt" style="position:absolute; left:56px; top:446px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">올해 </span><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">11</span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">21</span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">일</span></div>
<div class="txt" style="position:absolute; left:56px; top:462px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">판매허가 기대</span></div>
<div class="txt" style="position:absolute; left:56px; top:542px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽에서도 인정받은</span></div>
<div class="txt" style="position:absolute; left:56px; top:558px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">세노바메이트</span></div>
<div class="txt" style="position:absolute; left:191px; top:418px;"><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">4. </span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">세노바메이트</span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">: </span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">블록버스터 탄생을 예고</span></div>
<div class="txt" style="position:absolute; left:191px; top:444px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">올해 판매허가 획득이 예상되는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜의 또 다른 신약은 뇌전증</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(epilepsy)</span></div>
<div class="txt" style="position:absolute; left:191px; top:460px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">치료제 세노바메이트</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(YKP-3089)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. 2018</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">11</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FDA</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">NDA(New Drug</span></div>
<div class="txt" style="position:absolute; left:191px; top:476px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Application)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 신청했고 올해 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">11</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">21</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">일 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FDA</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 판매허가 여부가 결정된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">판</span></div>
<div class="txt" style="position:absolute; left:191px; top:492px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">매허가를 받으면 론칭은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2020</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 중에 이루어질 전망이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">판매 및 마케팅은 미</span></div>
<div class="txt" style="position:absolute; left:191px; top:508px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">국 뉴저지 현지법인인 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">라이프사이언스를 통해 독자적으로 수행될 계획이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:191px; top:540px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">한편 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜은 지난 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">14</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">일 스위스의 아벨 테라퓨틱스</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(Arvelle</span></div>
<div class="txt" style="position:absolute; left:191px; top:556px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Therapeutics)</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">와 유럽 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">32</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">개 국가 대상으로 기술수출 계약 체결을 공시했다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">기</span></div>
<div class="txt" style="position:absolute; left:191px; top:572px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">술수출 총 계약금은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">5.3</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러로 반환의무가 없는 계약금 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러와 마일스톤 기</span></div>
<div class="txt" style="position:absolute; left:191px; top:588px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">술료 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4.3</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러로 이루어져 있다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">매출이 시작되면 로열티도 수령하게 된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가까</span></div>
<div class="txt" style="position:absolute; left:191px; top:604px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">운 시일 내에 글로벌 임상 데이터를 토대로 유럽 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">EMA</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">NDA</span><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">를 제출할 계획이</span></div>
<div class="txt" style="position:absolute; left:191px; top:620px;"><span id="f4" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:191px; top:650px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">6&gt; </span><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">아벨테라퓨틱스와 기술수출 계약내용</span></div>
<div class="txt" style="position:absolute; left:191px; top:668px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">계약상대방</span></div>
<div class="txt" style="position:absolute; left:273px; top:668px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">총 계약금액</span></div>
<div class="txt" style="position:absolute; left:344px; top:668px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">계약금</span></div>
<div class="txt" style="position:absolute; left:191px; top:690px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">아벨테라퓨틱스</span></div>
<div class="txt" style="position:absolute; left:279px; top:690px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5.3</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러</span></div>
<div class="txt" style="position:absolute; left:341px; top:690px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러</span></div>
<div class="txt" style="position:absolute; left:191px; top:715px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: SK, </span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:383px; top:668px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">내용</span></div>
<div class="txt" style="position:absolute; left:383px; top:681px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">세노바메이트의 유럽판권에 대한 권리이전</span></div>
<div class="txt" style="position:absolute; left:383px; top:690px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">반환의무없는 계약금 </span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억달러</span></div>
<div class="txt" style="position:absolute; left:383px; top:699px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">아벨에서 </span><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">EMA</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">에 신약판매허가 제출 예정</span></div>
<div class="txt" style="position:absolute; left:526px; top:802px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(128,128,128,1);">7</span></div>
</body>
</html>
